319 related articles for article (PubMed ID: 30346453)
1. Ultrasound-targeted photodynamic and gene dual therapy for effectively inhibiting triple negative breast cancer by cationic porphyrin lipid microbubbles loaded with HIF1α-siRNA.
Sun S; Xu Y; Fu P; Chen M; Sun S; Zhao R; Wang J; Liang X; Wang S
Nanoscale; 2018 Nov; 10(42):19945-19956. PubMed ID: 30346453
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound assisted gene and photodynamic synergistic therapy with multifunctional FOXA1-siRNA loaded porphyrin microbubbles for enhancing therapeutic efficacy for breast cancer.
Zhao R; Liang X; Zhao B; Chen M; Liu R; Sun S; Yue X; Wang S
Biomaterials; 2018 Aug; 173():58-70. PubMed ID: 29758547
[TBL] [Abstract][Full Text] [Related]
3. Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled
You Y; Liang X; Yin T; Chen M; Qiu C; Gao C; Wang X; Mao Y; Qu E; Dai Z; Zheng R
Theranostics; 2018; 8(6):1665-1677. PubMed ID: 29556348
[TBL] [Abstract][Full Text] [Related]
4. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer.
Chen WH; Lecaros RL; Tseng YC; Huang L; Hsu YC
Cancer Lett; 2015 Apr; 359(1):65-74. PubMed ID: 25596376
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts.
Jing Y; Xiu-Juan Z; Hong-Jiao C; Zhi-Kui C; Qing-Fu Q; En-Sheng X; Li-Wu L
J Cancer Res Clin Oncol; 2019 May; 145(5):1191-1200. PubMed ID: 30805775
[TBL] [Abstract][Full Text] [Related]
7. Dihydroartemisinin Increases the Sensitivity of Photodynamic Therapy Via NF-κB/HIF-1α/VEGF Pathway in Esophageal Cancer Cell in vitro and in vivo.
Li Y; Sui H; Jiang C; Li S; Han Y; Huang P; Du X; Du J; Bai Y
Cell Physiol Biochem; 2018; 48(5):2035-2045. PubMed ID: 30099443
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound Triggered Conversion of Porphyrin/Camptothecin-Fluoroxyuridine Triad Microbubbles into Nanoparticles Overcomes Multidrug Resistance in Colorectal Cancer.
Chen M; Liang X; Gao C; Zhao R; Zhang N; Wang S; Chen W; Zhao B; Wang J; Dai Z
ACS Nano; 2018 Jul; 12(7):7312-7326. PubMed ID: 29901986
[TBL] [Abstract][Full Text] [Related]
9. Enhancing Photodynamic Therapy Efficacy Against Cancer Metastasis by Ultrasound-Mediated Oxygen Microbubble Destruction to Boost Tumor-Targeted Delivery of Oxygen and Renal-Clearable Photosensitizer Micelles.
Xu Y; Liu R; Yang H; Qu S; Qian L; Dai Z
ACS Appl Mater Interfaces; 2022 Jun; 14(22):25197-25208. PubMed ID: 35615986
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin-Targeting and Cathepsin B-Activatable Theranostic Nanoprobe for MR/Fluorescence Imaging and Enhanced Photodynamic Therapy for Triple Negative Breast Cancer.
Wang Y; Jiang L; Zhang Y; Lu Y; Li J; Wang H; Yao D; Wang D
ACS Appl Mater Interfaces; 2020 Jul; 12(30):33564-33574. PubMed ID: 32633941
[TBL] [Abstract][Full Text] [Related]
11. MnO
Li P; Tan X; Dan Q; Hu A; Hu Z; Yang X; Bai J; Chen X; Li B; Cheng G; Liu L; Chen Y; Sun D; Shuai X; Zheng T
Biomater Sci; 2024 Mar; 12(6):1465-1476. PubMed ID: 38318975
[TBL] [Abstract][Full Text] [Related]
12. Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy.
Ji Z; Yang G; Shahzidi S; Tkacz-Stachowska K; Suo Z; Nesland JM; Peng Q
Cancer Lett; 2006 Dec; 244(2):182-9. PubMed ID: 16427735
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
14. Novel cell-penetrating peptide-loaded nanobubbles synergized with ultrasound irradiation enhance EGFR siRNA delivery for triple negative Breast cancer therapy.
Jing H; Cheng W; Li S; Wu B; Leng X; Xu S; Tian J
Colloids Surf B Biointerfaces; 2016 Oct; 146():387-95. PubMed ID: 27388967
[TBL] [Abstract][Full Text] [Related]
15. Cationic Polyporphyrins as siRNA Delivery Vectors for Photodynamic and Gene Synergistic Anticancer Therapy.
Zheng N; Luo X; Zhang Z; Wang A; Song W
ACS Appl Mater Interfaces; 2021 Jun; 13(23):27513-27521. PubMed ID: 34086446
[TBL] [Abstract][Full Text] [Related]
16. Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer.
Li S; Wei Q; Li Q; Zhang B; Xiao Q
Cancer Biol Ther; 2015; 16(6):866-75. PubMed ID: 25920936
[TBL] [Abstract][Full Text] [Related]
17. Light-Activated Core-Shell Nanoparticles for Spatiotemporally Specific Treatment of Metastatic Triple-Negative Breast Cancer.
Meng Q; Meng J; Ran W; Wang J; Zhai Y; Zhang P; Li Y
ACS Nano; 2018 Mar; 12(3):2789-2802. PubMed ID: 29462553
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic treatment with purpurin 18 effectively inhibits triple negative breast cancer by inducing cell apoptosis.
Huang P; Zhang B; Yuan Q; Zhang X; Leung W; Xu C
Lasers Med Sci; 2021 Mar; 36(2):339-347. PubMed ID: 32623604
[TBL] [Abstract][Full Text] [Related]
19. Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy.
Yehia L; Boulos F; Jabbour M; Mahfoud Z; Fakhruddin N; El-Sabban M
PLoS One; 2015; 10(6):e0129356. PubMed ID: 26046764
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal-Organic Framework Nanoparticles to Boost Cancer Immunotherapy.
Cai Z; Xin F; Wei Z; Wu M; Lin X; Du X; Chen G; Zhang D; Zhang Z; Liu X; Yao C
Adv Healthc Mater; 2020 Jan; 9(1):e1900996. PubMed ID: 31746153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
